AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $13,000 | -99.9% | 295 | -99.9% | 0.00% | -100.0% |
| Q3 2018 | $18,869,000 | -9.4% | 244,675 | -1.1% | 0.04% | -11.9% |
| Q2 2018 | $20,832,000 | +3.7% | 247,324 | +0.7% | 0.04% | -2.3% |
| Q1 2018 | $20,086,000 | +38.5% | 245,613 | -3.2% | 0.04% | +43.3% |
| Q4 2017 | $14,506,000 | +2.7% | 253,726 | +19.9% | 0.03% | -3.2% |
| Q3 2017 | $14,124,000 | – | 211,598 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |